Al-Basar International Journal of Ophthalmology

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 3  |  Issue : 2  |  Page : 44--49

Evaluation of ocular hypotensive effects of some drugs used in treatment of open angle glaucoma, at Alsaym Ophthalmic Hospital, Wad Medani, Sudan


MM Haitham1, IM Tajeldin2, Mamoun Mirghani Ahmed3 
1 Department of Pharmacology, Faculty of Pharmacy, International Africa University, Khartoum, Sudan
2 Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Gezira, Sudan
3 Department of Ophthalmology, Faculty of Medicine, University of Gezira, Alsayem Teaching Eye Hospital, Gezira, Sudan

Correspondence Address:
Mamoun Mirghani Ahmed
Department of Ophthalmology, Faculty of Medicine, University of Gezira, Alsayem Teaching Eye Hospital, Gezira
Sudan

Introduction: Glaucoma is a neurodegenerative disease. It is presented by a triad of elevated intraocular pressure (IOP), progressive optic nerve damage, and constriction of the peripheral visual field. Objectives: The aim of this study is to assess the ocular hypotensive effects of some drugs used in treatment of open angle glaucoma (OAG) at Alsaym Ophthalmic Hospital, Wad Medani, Sudan. Methodology: A cross-sectional hospital-based study was conducted at specialized ophthalmological health setting. Patients (n = 200) diagnosed with OAG and treated with different anti-glaucoma drugs were selected randomly to participate in this study. The ocular hypotensive effects of anti-glaucoma drugs were evaluated monthly for 4 successive months, by measuring the diurnal IOP for each patient, using tonometer. The obtained data were collected in especial data collection form and analyzed by IBM SPSS Inc. (IBM SPSS Statistics) Software;Group's Business Analytics Portfolio. Results: Monotherapy of timolol (eye drops 0.5% and 0.1% eye gel), betaxolol 0.5% eye drops produced significant reductions in the total mean of IOP, ranged between 4.4 and 6.1 mmHg, while travoprost 0.004% eye drops showed a remarkable reduction of 7.3 mmHg. Combinations of travoprost with timolol and and/or dorzolamide 2% resulted in significant IOP lowering effects, ranged from 8.9 to 12.7 mmHg. Mono or combined therapy with travoprost was found to be superior to other anti-glaucoma monotherapy. Conclusion: The obtained results showed that travoprost produced clinical significant and superior ocular hypotensive effects when used alone or in combination with timolol and/or dorzolamide. It is thus recommended to use prostaglandin analogues in treatment of OAG because they are the most effective agents in reducing the mean diurnal IOP.


How to cite this article:
Haitham M M, Tajeldin I M, Ahmed MM. Evaluation of ocular hypotensive effects of some drugs used in treatment of open angle glaucoma, at Alsaym Ophthalmic Hospital, Wad Medani, Sudan.Albasar Int J Ophthalmol 2015;3:44-49


How to cite this URL:
Haitham M M, Tajeldin I M, Ahmed MM. Evaluation of ocular hypotensive effects of some drugs used in treatment of open angle glaucoma, at Alsaym Ophthalmic Hospital, Wad Medani, Sudan. Albasar Int J Ophthalmol [serial online] 2015 [cited 2021 Mar 6 ];3:44-49
Available from: https://www.bijojournal.org/article.asp?issn=1858-6538;year=2015;volume=3;issue=2;spage=44;epage=49;aulast=Haitham;type=0